Robin McKenzie

Associate Professor

1985 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Robin McKenzie is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Enterotoxigenic Escherichia coli Medicine & Life Sciences
Placebos Medicine & Life Sciences
Diarrhea Medicine & Life Sciences
Vaccines Medicine & Life Sciences
enterotoxigenic Escherichia coli Agriculture & Biology
Escherichia coli Vaccines Medicine & Life Sciences
Anti-Bacterial Agents Medicine & Life Sciences
Volunteers Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2019

Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection Model

Savarino, S. J., McKenzie, R., Tribble, D. R., Porter, C. K., O'Dowd, A., Sincock, S. A., Poole, S. T., Denearing, B., Woods, C. M., Kim, H., Grahek, S. L., Brinkley, C., Crabb, J. H. & Bourgeois, L., Jul 2 2019, In : Journal of Infectious Diseases. 220, 3, p. 505-513 9 p., jiz135.

Research output: Contribution to journalArticle

Open Access
Enterotoxigenic Escherichia coli
Anti-Idiotypic Antibodies
Diarrhea
Placebos
Infection

An evaluation of provider-chosen antibiotic indications as a targeted antimicrobial stewardship intervention

Timmons, V., Townsend, J., McKenzie, R., Burdalski, C. & Adams-Sommer, V., Jan 1 2018, (Accepted/In press) In : American Journal of Infection Control.

Research output: Contribution to journalArticle

Anti-Bacterial Agents
Fluoroquinolones
Documentation
Vancomycin
Odds Ratio

Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score

Porter, C. K., Lynen, A., Riddle, M. S., Talaat, K. R., Sack, D. A., Gutiérrez, R. L., McKenzie, R., DeNearing, B., Feijoo, B., Kaminski, R. W., Taylor, D. N., Kirkpatrick, B. D. & Bourgeois, L., Mar 1 2018, In : PLoS One. 13, 3, e0194325.

Research output: Contribution to journalArticle

Shigella
endpoints
standardization
disease severity
Standardization

Procalcitonin-guided antibiotic therapy reduces antibiotic use for lower respiratory tract infections in a United States medical center: Results of a clinical trial

Townsend, J., Adams, V., Galiatsatos, P., Pearse, D. B., Pantle, H., Masterson, M., Kisuule, F., Jacob, E., Kiruthi, C., Ortiz, P., Agbanlog, A., Jurao, R., Stern, S., Nayak, S., Melgar, M., Sama, J., Irwin, J., Mazidi, C., Psoter, K. & McKenzie, R., Jan 1 2018, In : Open Forum Infectious Diseases. 5, 12

Research output: Contribution to journalArticle

Open Access
Calcitonin
Respiratory Tract Infections
Clinical Trials
Anti-Bacterial Agents
Therapeutics

Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial

Savarino, S. J., McKenzie, R., Tribble, D. R., Porter, C. K., O'Dowd, A., Cantrell, J. A., Sincock, S. A., Poole, S. T., Denearing, B., Woods, C. M., Kim, H., Grahek, S. L., Brinkley, C., Crabb, J. H. & Bourgeois, L., Jul 1 2017, In : Journal of Infectious Diseases. 216, 1, p. 7-13 7 p.

Research output: Contribution to journalArticle

Enterotoxigenic Escherichia coli
Diarrhea
Placebos
Antibodies
Fimbriae Proteins